Stay updated on Triple-Negative Breast Cancer Adjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Triple-Negative Breast Cancer Adjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Triple-Negative Breast Cancer Adjuvant Therapy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record now lists a publication reporting the randomized phase II OXEL study of adjuvant nivolumab, capecitabine, or their combination for residual triple-negative breast cancer.
    Difference
    0.1%
    Check dated 2026-11-14T12:28:36.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner about NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed.
    Difference
    1%
    Check dated 2026-11-07T11:47:10.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:14:08.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:06:41.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now shows revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T12:35:06.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:56:44.000Z thumbnail image

Stay in the know with updates to Triple-Negative Breast Cancer Adjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Triple-Negative Breast Cancer Adjuvant Therapy Clinical Trial page.